title: Luteinizing-hormone-releasing hormone agonist treatment in patients with previously failed folliculogenesis during in vitro fertilization therapy.
authors.affiliation: Department of Obstetrics and Gynaecology, Monash University, Melbourne, Australia.
authors.forename: V
authors.initials: V
authors.lastname: MacLachlan
authors.forename: M
authors.initials: M
authors.lastname: Besanko
authors.forename: H
authors.initials: H
authors.lastname: Wade
authors.forename: L
authors.initials: L
authors.lastname: Morrow
authors.forename: F
authors.initials: F
authors.lastname: O'Shea
authors.forename: A
authors.initials: A
authors.lastname: Trounson
authors.forename: D
authors.initials: D
authors.lastname: Healy
mesh_terms: D002064:Buserelin / Q000627:therapeutic use*; D004958:Estradiol / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008597:Menstrual Cycle; D017274:Nafarelin; D006080:Ovarian Follicle / Q000187:drug effects / Q000502:physiology*; D010060:Ovulation / Q000187:drug effects
chemical_list: D017274:Nafarelin; D007987:Gonadotropin-Releasing Hormone; D004958:Estradiol; D002064:Buserelin